S-adenosylmethionine decarboxylase (AdoMetDC) is a key enzyme in the synthesis of polyamines essential for cell growth and proliferation. Its overexpression induces the transformation of murine fibroblasts in both sense and antisense orientations, yielding highly invasive tumors in nude mice. These cell lines hence provide a good model to study cell invasion. Here, the gene expression profiles of these cells were compared with their normal counterpart by microarray analyses (Incyte Genomics, Palo Alto, CA, and Affymetrix, Santa Clara, CA). Up-regulation of the actin sequestering molecule thymosin B4 was the most prominent change in both cell lines. Tetracycline-inducible expression of thymosin B4 antisense RNA caused a partial reversal of the transformed phenotype. Further, reversal of transformation by dominantnegative mutant of c-Jun (TAM67) caused reduction in thymosin B4 mRNA. Interestingly, a sponge toxin, latrunculin A, which inhibits the binding of thymosin B4 to actin, was found to profoundly affect the morphology and proliferation of the AdoMetDC transformants and to block their invasion in three-dimensional Matrigel. Thus, thymosin B4 is a determinant of AdoMetDC-induced transformed phenotype and invasiveness. Up-regulation of thymosin B4 was also found in ras-transformed fibroblasts and metastatic human melanoma cells. These data encourage testing latrunculin A-like and other agents interfering with thymosin B4 for treatment of thymosin B4-overexpressing tumors with high invasive and metastatic potential. (Cancer Res 2006; 66(2): 701-12) 
Introduction
S-adenosylmethionine decarboxylase (AdoMetDC; EC 4.1.1.50) is one of the two key regulatory enzymes in the biosynthetic pathway of polyamines (putrescine, spermidine, and spermine), the other being ornithine decarboxylase (ODC; EC 4.1.1.17). ODC catalyzes the synthesis of putrescine, and AdoMetDC catalyzes the formation of decarboxylated S-adenosylmethionine, which is used as an aminopropyl donor in the conversion of putrescine to spermidine and spermine. Polyamines are essential for normal cell growth. If cells are depleted of their polyamine reservoirs, by using inhibitors of the polyamine biosynthetic enzymes or polyamine biosynthesisdeficient mutants, they cease to proliferate. The activities of both AdoMetDC and ODC are rapidly increased after growth factor stimulus, and these inductions together with the exceptionally fast intracellular turnover rates of these enzymes provide the cells with a means of rapidly regulating their polyamine levels (1) (2) (3) (4) . A tight regulation of polyamine biosynthesis is important for normal cell growth. Indeed, aberrant elevation of the activities and expression levels of ODC and AdoMetDC may be associated with the development of cancers, including prostatic, breast, colorectal, and hepatocellular tumors (2, (5) (6) (7) (8) (9) (10) (11) . Furthermore, overexpression of both ODC and AdoMetDC, by themselves, has been shown to induce tumorigenic cell transformation of rodent cells (12) (13) (14) (15) (16) (17) . Murine NIH3T3 fibroblast cells transfected with AdoMetDC cDNA in either sense or antisense orientation were paradoxically both transformed and highly invasive, invading rapidly into the peritoneal cavity when inoculated s.c. into the flanks of nude mice (17) . As these cell lines are even more invasive than the HT-1080 fibrosarcoma cells, MDA-MB-231 breast cancer cells, and c-Haras Val12 oncogene-transformed fibroblasts (18), 3 they provide a good model for studies of invasive growth.
The aim of the current work was to elucidate the gene expression alterations behind the transformed morphology and invasive behavior of the two AdoMetDC-transfected cell lines compared with their normal counterpart. In particular, we were interested in studying whether the apparently different signaling pathways in these sense and antisense cDNA-expressing cells could ultimately lead to common alterations in gene expression, typifying the transformed phenotype. The gene expression levels were compared by two different microarray systems: cDNA array (Incyte Genomics LifeArrays, Palo Alto, CA, 9,596 expressed elements) and oligonucleotide array (Affymetrix GeneChip, Santa Clara, CA, 12,654 elements). The former represents a competitive hybridization of two differently fluorescently labeled RNA samples to cDNA fragments (average length, 1,000 bp) immobilized onto glass slides, and the latter is based on two independent hybridizations of biotinylated cRNA samples to glass-immobilized oligonucleotides (25-mers) and fluorescent detection using antibody amplification.
Our studies revealed that the most marked gene expression change in both cell lines was a large increase in the mRNA level of the actin sequestering protein thymosin h4. The functional significance of this increase was further studied by in vitro transfection assays using reverse tetracycline-inducible retroviral expression vector-driven thymosin h4 antisense RNA expression and small interfering RNAs (siRNA) to thymosin h4. In addition, the association of thymosin h4 overexpression with transformation was also detected in AdoMetDC-sense cell lines carrying a tetracycline-inducible expression system of a transactivation domain deletion mutant of the oncogenic transcription factor c-Jun (TAM67), allowing reversible regulation of transformation. Further, the studies on thymosin h4 expression were extended to c-Ha-ras oncogene-transformed fibroblasts and to normal human melanocytes and melanoma cell lines isolated from primary and metastatic tumors and clinical melanoma metastases. Finally and most interestingly, an actin-binding sponge toxin, latrunculin A, which inhibits the binding of thymosin h4 to actin (19) , was discovered to have a remarkable effect on the morphology, proliferation, and invasion of the AdoMetDC transformants, whereas normal fibroblasts were only slightly affected.
Materials and Methods
Cell culture. NIH3T3 cells transfected with a pLTRpoly-vector carrying human AdoMetDC cDNA in sense and antisense orientations (17) or a vector carrying c-Ha-ras Val12 oncogene (pGEJ6.6; ref. 20) have been described previously. The resulting transfectants with the empty vector (4N) and AdoMetDC cDNA in sense and antisense orientations (Amdc-s and Amdc-as, respectively) and the ras transformants (E4) were cultured in DMEM supplemented with antibiotics, G418, and 5% newborn calf serum or FCS (both from Invitrogen, Carlsbad, CA). To prevent the counterselection of cells expressing AdoMetDC-antisense mRNA at the levels sufficient to block the synthesis of essential polyamines, a low concentration (1 Amol/L) of spermidine was added to the growth medium of Amdc-as cells (17) . Human primary melanocytes (42V; kindly provided by Dr. O. Saksela, University of Helsinki, Helsinki, Finland) were cultured as described previously (21) . The melanoma cell lines, WM793 and WM239, established from a vertical growth phase melanoma primary tumor and melanoma metastasis, respectively, were kindly provided by Dr. M. Herlyn (Wistar Institute, Philadelphia, PA). They were both cultured in RPMI 1640 supplemented with 10% FCS and antibiotics.
Cell lines carrying a tetracycline-inducible expression system of the transactivation domain deletion mutant of c-Jun (pLRT-TAM67). The tetracycline-inducible TAM67 expression construct (pLRT-TAM67) was generated and transfected into Amdc-s cells identically to that described for the ODC and ras transformants (22) . Several clones (transformed foci) of the stable transfectants were picked up by cylinder cloning, and after initial screening, the ones with the best induction were further subjected to single-cell cloning in 96 wells. For induction of TAM67 expression, 1 Ag/mL doxycycline (Sigma, St. Louis, MO) was added the day after plating.
Microarray analysis with Incyte Genomics mouse GEM 2/Unigene 1 LifeArrays. Polyadenylated RNA was extracted from the exponentially growing cells by oligo(dT) cellulose affinity chromatography (Roche Diagnostics GmbH, Mannheim, Germany) as reported previously (23) , and the possible genomic DNA carryover was destroyed by 1-hour RNase-free DNase I treatment (Roche Diagnostics GmbH). After that, the samples were further purified with Oligotex mRNA Mini kit (Qiagen, Hilden, Germany) according to the manufacturer's instructions. Polyadenylated RNA was then reverse transcribed with Cy3 and Cy5 end-labeled random 9-mers to generate fluorescent single-stranded cDNA probes, which were competitively hybridized to Incyte Genomics mouse GEM 2/Unigene 1 LifeArrays. The analyses were repeated twice. Mouse GEM 2/Unigene 1 contained 9,596 elements, corresponding to 9,307 total unique genes/clusters.
Microarray analysis with Affymetrix GeneChip murine genome arrays. For the analysis with Affymetrix microarrays, total RNA (>200 bases) was extracted from the exponentially growing cells with the RNeasy Midi kit and the RNase-Free DNase Set (Qiagen) according to the manufacturer's instructions. Biotinylated cRNA targets were then prepared from the samples and hybridized to MGU74A and MOE430 Set arrays according to the Affymetrix GeneChip Expression Analysis Technical Manual. The analyses were repeated twice. The total number of genes was 12,654 in MGU74A arrays and >30,000 in MOE430 Set arrays.
Thymosin B4 vectors. To construct tetracycline-inducible retroviral thymosin h4 antisense RNA expression vector, the 135-bp rat thymosin h4 cDNA (coding region) cloned in pT7-7 vector (between NdeI and EcoRI restriction sites; a generous gift from Dr. D. Safer, University of Pennsylvania, Philadelphia, PA) was released by XbaI and EcoRI, subcloned into pBluescript, and finally inserted in reversed orientation into the inducible pLRT expression vector (24) using XhoI and NotI. The correctness of the cloned thymosin h4 antisense construct was confirmed by DNA sequencing (ABI PRISM 3100 Genetic Analyzer).
Northern blot analysis. The thymosin h4 mRNA levels of the normal 4N fibroblasts, Amdc-s and Amdc-as cells, ras-transformed cells, and tetracycline-inducible TAM67-expressing derivatives of Amdc-s as well as those of the 42V melanocytes, WM793 and WM239 melanoma cells, and clinical melanoma metastases were confirmed by Northern blot analysis. The polyadenylated RNA samples (10 Ag; fibroblasts) or total RNAs (30 Ag; melanocytes and melanoma cells) were resolved in agarose gels and transferred to Hybond-N nylon membrane (Amersham Pharmacia Biotech, Buckinghamshire, United Kingdom) as described previously (25) . The hybridizations were done according to Clontech's (Palo Alto, CA) ''Hybridization with cDNA Probes'' manual using the ExpressHyb hybridization solution (Clontech, Palo Alto, CA). The single-stranded thymosin h4 antisense RNA probe was generated from the linearized pBlue-thymosin h4-vector (thymosin h4 flanked by T3 and T7 RNA polymerase promoters) by using MAXIscript T7/T3 In vitro Transcription kit (Ambion, Inc., Austin, TX) and [a- Transfection experiments. The transformed Amdc-s and Amdc-as cells were transfected with the pLRT-thymosin h4-antisense vector (2 Ag/5 cm diameter plate) using LipofectAMINE Plus reagent (Invitrogen) according to the instructions. To obtain stable cell lines, blasticidin S selection (5 Ag/mL; Invitrogen) was started 2 days after transfection and continued for 2 weeks, after which the concentration was diminished to 1.25 Ag/mL. The expression of thymosin h4 antisense RNA was induced by the addition of 1 Ag/mL doxycycline immediately after transfection, the next day or later, to study the effects of the timing of induction. As a control, doxycycline was also added to normal Amdc-s and Amdc-as cells (transfected or not with empty thymosin h4 vector) with no effects. To maximize the effect of doxycycline induction, the cells were grown with Tet System-approved fetal bovine serum (BD Biosciences, Palo Alto, CA). The pools of transfected cells were further subjected to cylinder cloning to study individual clones.
Transfection with siRNA oligonucleotides. The siRNA oligonucleotides to thymosin h4 were synthesized by Dharmacon Research, Inc. (Lafayette, CO). The two siRNA oligonucleotides tested were targeted to the 5V -AACAAGAGAAGCAAGCUGGCC-3V and 5V -AAGAGAAGCAAGCUGGC-GAAU-3Vsequences of the mouse thymosin h4 mRNA coding region. The negative control siRNA was targeted to a scrambled sequence 5V -AAAGGAGAGGAUCGCACGCAC-3V . The Amdc-s and Amdc-as cells (1 Â 10 5 ) were transfected with siRNAs (50-200 nmol/L) in six-well plates using Oligofectamine and LipofectAMINE 2000 (both from Invitrogen) or Fugene 6 (Roche Diagnostics GmbH) reagents following the manufacturer's protocols. The cells were observed daily, changing medium with the siRNAs every 3 days. Total RNAs were extracted from the cells with RNeasy Mini columns after 3, 6, and 9 days of culture.
Reverse transcription-PCR analysis. The expression of thymosin h4 and thymosin h10 mRNAs and thymosin h4 antisense RNA were analyzed by reverse transcription-PCR (RT-PCR). Total RNA was extracted from the exponentially growing cells and reverse transcribed to cDNA using avian myeloblastosis virus reverse transcriptase (20 units; Finnzymes, Espoo, Finland) and oligo(dT) primer (12.5 pmol; Genset, Paris, France).
After the reverse transcription reaction, 1:10 (v/v) aliquots of the reversetranscribed RNAs were subjected to PCR amplification. The primers for PCR were from Proligo (Paris, France) unless otherwise specified. The primers were 5V -CCTCATCCTCCTCGTCCTTA-3V ( forward) and 5V -TGATC-CAACCTCTTTGCATC-3V (reverse) for thymosin h4 mRNA and 5V -GTAA-GAAAATGGCAGACAAGCC-3V and 5V -AGTCCGATTAGTGGAGGG-3V for thymosin h10 mRNA. For thymosin h4 antisense RNA, the forward primer was specific for the pLRT-vector (5V -CCTACAGGTGGGGTCTTTCA-3V ; Genset) and the reverse was specific for the thymosin h4 antisense RNA (5V -TCGCCAGCTTGCTTCTCTTG-3V ). As a control, the samples were also amplified using glyceraldehyde-3-phosphate dehydrogenase (GAPDH) mRNA primers 5V -GGGTGTGAACCACGAGAAAT-3Vand 5V -GGTCCTCAGTG-TAGCCCAAG-3V . A negative control contained all constituents but not the template cDNA (H 2 O or RNA instead). The PCR reactions, optimized to be in the linear range, consisted of initial denaturation (94jC for 2 minutes) followed by 23 cycles (thymosin h4-antisense) or 30 cycles (thymosin h4, thymosin h10, and GAPDH) of 94jC for 30 seconds, 50jC, 56jC, 59jC, or 62jC (thymosin h10, thymosin h4, GAPDH, and thymosin h4-antisense, respectively) for 45 seconds, and 72jC for 40 seconds and a final elongation at 72jC for 7 minutes. Products were resolved in 2% agarose gel and the gel was stained with SYBR Green I nucleic acid gel stain (Molecular Probes, Leiden, the Netherlands) to allow visualization of the bands under UV light. The gels were documented with Gel Doc 2000 and Quantity One 4.2.3 software (Bio-Rad, Hercules, CA).
Immunofluorescence staining. Cells were grown on glass coverslips, fixed with 3.5% paraformaldehyde, permeabilized with 0.1% Triton X-100, and stained with rabbit anti-thymosin h4 antibody (amino acids 1-43; Biodesign, Saco, ME) and TRITC-labeled anti-rabbit antibody (DAKO, Glostrup, Denmark).
Effect of latrunculin A on cell morphology and growth. To test the effect of latrunculin A on the cell morphology, latrunculin A (100 and 350 ng/mL; Molecular Probes) was added to 4N, Amdc-s and Amdc-as cells 2 days after plating. The morphology of the cells was followed at 5-to 20-minute intervals during the first hours and then checked daily. In a longer follow-up, medium with latrunculin A was changed twice weekly and the detached cells were harvested by centrifugation. To test the ability of the cells to restore the normal morphology, the medium with latrunculin A was replaced with medium without the toxin at different time points. To see the effect of latrunculin A on the growth of the normal and AdoMetDC transfected cells, 10,000 to 15,000 cells were plated onto 12-well plates 2 days before addition of latrunculin A (50, 100, and 350 ng/mL) and the total number of cells was counted 0, 1, 2, and 3 days after the addition with a Coulter particle counter (Beckman Coulter, Fullerton, CA). All measurements were made in triplicates. Growth assays were repeated four times with similar results.
Three-dimensional collagen gel migration/invasion assay. Threedimensional collagen lattices were prepared in 24-well plates. Rat tail collagen type 1 solution (4 mg/mL; Upstate Biotechnology, Lake Placid, NY) was mixed in a ratio of 1:1 with 2Â DMEM containing 10% FCS. About 400 AL of this collagen solution (supplemented or not with 1 Ag/mL doxycycline) were added to the wells and allowed to polymerize at 37jC for 30 minutes. Then, 20,000 Amdc-s or Amdc-s-pLRT-thymosin h4-as cells (pretreated or not with 1 Ag/mL doxycycline for 36 hours) were added in 100 AL DMEM containing 5% FCS. The cells were allowed to attach for 1 hour at 37jC, and the excess medium was removed. Next, an upper collagen gel (300 AL) was cast. After polymerization at 37jC for 30 minutes, DMEM (500 AL) containing 5% FCS, supplemented or not with 1 Ag/mL doxycycline, was added on the top. The growth medium was changed after every 3 days.
Three-dimensional Matrigel invasion assay. Invasiveness of Amdc-s and Amdc-as cell lines in growth factor-reduced Matrigel (BD Biosciences) was inspected without and with latrunculin A (25, 50, and 100 ng/mL) essentially as reported earlier (18), but with latrunculin A included in the Matrigel and the upper medium. The toxin was not present in the medium during adhesion of the cells. The growth patterns of the cells were observed under a microscope daily for at least 1 week and the growth medium was changed every third day. To see the effect of latrunculin A on the already formed invasive colonies, a final concentration of 100 ng/mL was added to the culture. After 4 days, the Matrigel was then solubilized by 4.5-hour incubation on ice and dilution with ice cold medium, and the cells were recovered by centrifugation and plated onto six-well plates without the toxin. The Matrigel assays were repeated thrice with similar results. As a control, 4N cells were treated in the same way.
Results
AdoMetDC-sense-and AdoMetDC-antisense-expressing cells show similar gene expression patterns. Microarray analysis of the AdoMetDC-sense-and AdoMetDC-antisense-expressing transformed fibroblasts (Amdc-s and Amdc-as, respectively) compared with wild type cells (4N) showed strikingly similar changes in their gene expression profiles. We used two microarray systems, the Incyte Genomics Mouse GEM2/Unigene 1 cDNA array and the Affymetrix MGU74A oligonucleotide array. Both systems identified thymosin b4 and cellular retinoic acid-binding protein I as genes showing the highest increase in expression (Tables 1 and 2 ). Several other changes common to both systems were detected, including increased expression of cathepsin L, integrins b 7 and a 6 , chondroitin sulfate proteoglycan 2, proliferin, decorin, kit ligand, protocadherin 7, and osteopontin and decreased expression of serine protease (hypothetical 43-kDa protein), microfibrillar-associated protein 5, thrombospondin 1, procollagen type I a1, Ly-6 alloantigen, cysteine-rich protein 61, serum-inducible kinase, and phosphatidic acid phosphatase 2a (marked in bold in Tables 1 and 2 ). The level of AdoMetDC mRNA expression served as a good control and was f4 to 10 times up-regulated in the Amdc-s cells compared with the 4N control cell line (in the Affymetrix arrays containing the gene; data not shown). Our microarray analysis thus identified a defined set of genes with differential expression associated with the transformed phenotype of AdoMetDC-transfected cells. It is noteworthy that thymosin b4 and cellular retinoic acid-binding protein I were also the two most up-regulated genes in the global gene expression analyses by Affymetrix MOE430 Set arrays (data not shown). The functional significance of thymosin h4 up-regulation was further explored in this study, because cellular retinoic acid-binding protein I was not up-regulated in c-Ha-ras oncogene-transformed cells (data not shown), implicating that it is not a universal change in invasive fibroblasts.
Validation of thymosin B4 overexpression. The overexpression of thymosin h4 mRNA in AdoMetDC transfectants was verified by Northern blot (Fig. 1) and RT-PCR (data not shown) analyses. A substantial increase in thymosin h4 mRNA expression was observed in both Amdc-s and Amdc-as cells compared with the normal 4N control (Fig. 1A) . A similar increase in thymosin h4 mRNA was also detected in ras-transformed fibroblasts (Fig. 1A) . In addition, the levels of thymosin h4 protein were found to be increased in the transformed cells by immunofluorescence staining (Fig. 1D) .
We have shown previously that the c-Jun/activator protein-1 (AP-1) dominant-negative mutant TAM67 can reverse the ODCand ras-induced transformation of fibroblasts (22) . Here, the same was found to be true for the AdoMetDC-induced transformation. To determine whether this occurred via the regulation of thymosin h4, we used tetracycline-inducible Amdc-s-pLRT-TAM67 cells and found that TAM67 inhibited the expression of thymosin h4 mRNA (Fig. 1B) . We further studied the expression of thymosin h4 in normal human melanocytes and malignant melanoma cells. The expression of thymosin h4 was low in normal melanocytes (42V) and early vertical growth phase melanoma cells (WM793) but high in metastasized melanoma cells (WM239) and clinical metastases (Fig. 1C) . These findings are in line with a recent study (26) and suggest that thymosin h4 overexpression is associated with a more aggressive transformed cell type.
Thymosin B4 antisense expression affects the transformed phenotype. To determine if thymosin h4 expression is required for the transformed phenotype of AdoMetDC-overexpressing fibroblasts, cells with tetracycline-inducible antisense thymosin h4 were prepared by stable transfection. In RT-PCR analyses, thymosin h4 antisense RNA-specific primers detected a 0.4-kb product that was amplified from total RNA of thymosin h4 antisense-transfected Amdc-s and Amdc-as cells ( Fig. 2A , shown for Amdc-s cells). The band was detectable in uninduced transfectants albeit at a much lower level than that observed in doxycycline-treated cells. This was probably due to leakiness of the pLRT-thymosin h4-antisense construct. Control cells transfected with the empty pLRT vector had no corresponding band. These results confirm the specific expression of thymosin h4 antisense message. Inducible inhibition of thymosin h4 expression in these cells resulted in a morphology change to (Fig. 2B) . The degree of flattened morphology varied, however, among the cells even in isolated clones. The effect was most extensive immediately after transfection and induction. At times long after transfection, the inducibility was weakened. Similar results were observed with siRNA to thymosin h4 (data not shown). This is likely due to some compensating mechanisms taking place in the thymosin h4 antisense RNAexpressing cells. The possibility that the thymosin h10 isoform (expressed at the same levels in normal and AdoMetDCtransfected cells) would show a compensatory increase was excluded by RT-PCR (data not shown). We also studied the cellular behavior of the transfectants in three-dimensional collagen gel assays, mimicking more closely the physiologic growth conditions than the two-dimensional culture on plastic. As shown in Fig. 2C , the expression of thymosin h4 antisense RNA inhibited dispersion/migration of the Amdc-s cells in the three-dimensional system, resulting in cells growing adhered to each other as multicellular aggregates.
Latrunculin A, an inhibitor of thymosin B4 binding to actin, affects the morphology of Amdc-s and Amdc-as cells. To further study the potential functional significance of thymosin h4 overexpression, we used latrunculin A, a sponge toxin shown to interfere with thymosin h4 binding to actin (19) . Interestingly, the effect of latrunculin A on cell morphology was very different between the normal fibroblasts ( Fig. 3A and B) and the AdoMetDC transformants (Fig. 3C-H , shown for Amdc-s). Latrunculin A treatment at a concentration of 350 ng/mL for 35 minutes had little effect on the morphology of normal 4N cells (Fig. 3A and B) . Amdc-s and Amdc-as cells started to round up from the cell body region in <20 minutes after addition of only 100 ng/mL (Fig. 3C and D) , progressively becoming ball-and-stick model-looking cells with a round center and thin protrusions. The effect of latrunculin A was found to be cell density dependent, with the more sparse cultures being more sensitive to the toxin. With 350 ng/mL of the drug, the morphology changes occurred sooner and the protrusions further contracted, resulting in rounding of the cells that started to detach in <1 hour and become swollen ( Fig. 3E and F) . When the cell growth medium was replaced with toxin-free medium at this point, the attached cells recovered as fast as they initially had started to round up, resulting in nearly full recovery of the morphology after an overnight culture (data not shown). One day after the addition of 350 ng/mL latrunculin A, almost all the cells had rounded and detached. Replating of the detached cells in fresh medium without toxin resulted in attachment in <1 hour and the cells started to divide. Interestingly, the swollen cells seemed to rapidly give rise to groups of cells (Fig. 3G) , implicating arrested cell division, cytokinesis, as the cause of the swelling. When the detached cells were collected after 2-day culture in 350 ng/mL latrunculin A, they attached somewhat more inefficiently and did not recover fully. Many of the attached cells had multiple nuclei (data not shown). After 5 days of exposure to latrunculin A, the recovery of the cells was poor and nearly all the attached cells had multiple nuclei (Fig. 3H) . However, the detached cells were not apoptotic, as no activation/cleavage of caspase-3 was detected by immunoblotting (data not shown).
Latrunculin A inhibits the growth of AdoMetDC transformants. The effect of latrunculin A on cell growth was analyzed at different time points after addition of 0, 50, 100, and 350 ng/mL latrunculin A. Latrunculin A at these concentrations had little effect on the growth of normal 4N cells (Fig. 4A) . The growth of both Amdc-s and Amdc-as cells was effectively inhibited with as little as 50 ng/mL latrunculin A (Fig. 4B , shown for Amdc-s cells). In addition, the motility of the cells, as determined by woundscratch assay, was found to be differentially inhibited by latrunculin A (data not shown). As with the effect on morphology, the sensitivity of the cells to the latrunculin A-induced growth inhibition seemed to be cell density dependent, with less effect seen with more dense cultures (data not shown). The untreated 4N and Amdc-s cells had similar growth rates (Fig. 4A and B) , indicating that thymosin h4 overexpression itself does not affect the growth rate of fibroblasts.
Latrunculin A blocks invasion of Amdc-s and Amdc-as cells in three-dimensional Matrigel. When inoculated into nude mice, the thymosin h4-overexpressing Amdc-s and Amdcas cell lines gave rise to aggressively growing tumors, which rapidly invaded into the peritoneal cavity (17) . Similarly, they effectively invaded the surrounding basement membrane matrix in a three-dimensional Matrigel invasion assay (Fig. 5A, F , and G, shown for Amdc-s), correlating with the in vivo invasiveness in nude mice (18, 22) . When latrunculin A was added to the Matrigel matrix and the growth medium, the invasion was inhibited in a dose-dependent manner (Fig. 5A-C) . At 100 ng/mL of the toxin, the inhibition was almost complete (>95%) with both Amdc-s and Amdc-as cells (Fig. 5C ). The normal 4N control cells, which are not invasive in Matrigel, were not affected by latrunculin A (Fig. 5D and E) . When 100 ng/mL concentration of latrunculin A was added to the already formed invasive colonies, not only the invasion was inhibited but also the colonies started to shrink (Fig. 5F-H) . When Matrigel was solubilized 4 days after the latrunculin A addition, the cells were harvested and plated, they appeared enlarged and aberrantly shaped with multiple nuclei (Fig. 5I and J) . Their growth was also significantly impaired. Taken together, these results suggest that thymosin h4 functional activity is essential for the transformed phenotype and migration/invasion of AdoMetDC-expressing cells.
Discussion
Overexpression of AdoMetDC cDNA in both sense and antisense orientations results in morphologically transformed fibroblasts and induces highly invasive tumors in nude mice (17) . In this study, we compared the gene expression profiles of these two cell lines with their normal counterpart by microarray analyses and found only a surprisingly small set of common changes potentially relevant for transformation/invasion. They included genes regulating cytoskeletal structure, cell adhesion, and membrane trafficking: thymosin b4 and cytohesin-binding protein (increased); cell surface receptors/adhesion molecules: integrins a 6 and b 7 and protocadherin 7 (increased); extracellular matrix (ECM) components/modifiers: decorin, chondroitin sulfate proteoglycan 2, and hyaluronan synthase 2 (increased) and procollagen type I a1, microfibrillar-associated protein 5, and thrombospondin 1 (decreased); and ECM-degrading enzymes: cathepsin L and type IV collagenase (increased). Whether some of these diverse genes could be functionally coupled with some of the molecules acting as central linkers/mediators of the signaling in and out between the ECM, cell surface, and cytoskeleton remains a highly interesting object of further studies. For example, the cytohesin-binding protein might be one such integrator molecule, because in leukocytes cytohesin-1, a guanine nucleotide exchange activator of ADP ribosylation factor GTPases, is known to bind to integrin h 2 and actin cytoskeleton and to regulate cell adhesion and membrane trafficking (27) (28) (29) . Moreover, a couple of unknown genes [expressed sequence tags (EST), with increased or decreased expression] and as yet functionally uncharacterized proteins, such as serine protease (hypothetical 43-kDa protein) and LR8 (showing the largest decreases), were detected and will require further elucidation of their potential significance for transformation/invasion. Here, the functional significance of thymosin h4 was studied in more detail, as it showed the most striking increase in expression in the Amdc-s and Amdc-as cells and it was also highly increased in the c-Ha-ras Val12 oncogenetransformed fibroblasts and other cells (see below). The second most increased gene in the AdoMetDC-transformed cells, cellular retinoic acid-binding protein I, was proven not to be increased in the ras transformants and thus does not seem to represent a common transformational target in fibroblasts.
Thymosin h4, first characterized in 1981 (30) , is the most abundant member of the highly conserved family of h-thymosins, strongly polar 5-kDa polypeptides. Thymosin h4 was originally isolated from calf thymus and thought to be a secreted hormone but was later shown to be present in several mammalian tissues and cell lines (31) (32) (33) (34) . Thymosin h4 seems to be a major actin sequestering molecule, which specifically binds monomeric actin (G-actin) forming a 1:1 complex (35, 36) . Due to its high concentration in the cell, thymosin h4 sequesters a large pool of G-actin, from which the actin monomers can then easily be released for the polymerization of actin filaments (F-actin). This dynamic equilibrium of G-actin and F-actin is important for the rapid reorganization of the cytoskeleton, a process essential for cell proliferation, migration, and differentiation. Thymosin h4 seems to have numerous roles in the cells, both intracellular and extracellular. It has been reported to be involved in adhesion and spreading of fibroblasts (37, 38) , differentiation of endothelial cells (39, 40) , directional migration of endothelial cells and keratinocytes (41) (42) (43) (44) , angiogenesis (39-42, 45, 46) , wound healing (42, 43, 47, 48) , hair follicle growth (44) , and apoptosis (49, 50) , and to possess anti-inflammatory properties (47, 51) . Interestingly, elevated thymosin h4 expression levels have been observed in various malignant cell lines and tumors (52) (53) (54) (55) and its expression seems to be related to increased tumorigenicity and metastatic potential (26, 38, 46, 50, 56, 57) .
In our study, besides the AdoMetDC transfectants, we also identified thymosin h4 overexpression in ras-transformed NIH3T3 fibroblasts as well as in metastatic human melanoma cell lines and melanomas. In contrast, a cell line transformed by ODC, which is also tumorigenic in nude mice (13) , did not show a significant increase in thymosin h4 expression or high invasiveness (only local invasion). In our study, the increased expression of thymosin h4 correlated with the invasive capability of the cells as well as with the degree of morphologic transformation and disintegration of actin filaments (17) . 3 Recent work has also correlated increased thymosin h4 expression with increased cell growth (50, 57) , but this seems not to be universal (this study; refs. 38, 46) .
When the increased thymosin h4 expression of the AdoMetDC transfectants was inhibited, at least partly, by induced expression of thymosin h4 antisense RNA, the cell morphology became more flattened, resembling that of normal fibroblasts. In addition, the migration/invasion of the cells in three-dimensional collagen was inhibited, with the blocking of thymosin h4 possibly affecting the cytoskeletal regulation of cell-cell and cell-matrix interactions. The reversal of the transformed phenotype was, however, not complete in all the asynchronously growing cells probably because the inducible antisense message did not fully block the increased expression of thymosin h4 in all of them or due to some compensating mechanisms. Further, an apparent counterselection resulted in impairment of the inducibility of antisense RNA expression during prolonged culturing. The mechanism(s) of counterselection, noted also by others (58), remains to be elucidated. It also seems that the rapidity of the changes in thymosin h4 may have an effect on the outcome. Indeed, although microinjection of thymosin h4 has been found to cause disintegration of the actin filaments (59, 60), a slower (and probably less intense) increase in thymosin h4 by cDNA transfection may result in adaptation of the cells with formation of even stronger actin filaments through a concomitant increase in actin (37) . The same may conversely be reflected in the antisense/siRNA transfection experiments and inhibitor (e.g., latrunculin A) studies (see below).
Our data with a dominant-negative mutant of c-Jun/AP-1 (TAM67) showed the morphologic reversal of Amdc-s and diminished thymosin h4 expression levels. These results suggest a connection between thymosin h4 and c-Jun. Our kinetic analyses show that the decrease in thymosin h4 mRNA following TAM67 induction is a relatively slow process, suggesting that thymosin h4 may not be a direct target of c-Jun (data not shown).
As thymosin h4 up-regulation seems to be associated with cell transformation and high invasiveness, it could serve as a target for antitumor strategies. Recently, latrunculin A, an actin sequestering macrolide isolated from a Red Sea sponge, has been reported to inhibit the binding of thymosin h4 to actin (19) . In this study, we show that the addition of latrunculin A to thymosin h4-overexpressing Amdc-s and Amdc-as cells caused a rapid and dramatic change in the morphology of the cells, whereas minor effects were observed in normal fibroblasts. Previously, Spector et al. (61) have similarly reported that latrunculin A rapidly changes the morphology of mouse fibroblasts and neuroblastomas. A 10-fold difference existed in the sensitivity of the studied cell lines, with neuroblastomas being more sensitive. In the light of our results, the differential sensitivity could be explained by differences in the thymosin h4 levels. Indeed, Hall et al. (62, 63) found thymosin h4 protein to be abundant in human and rat neuroblastoma cell lines. However, it is possible that latrunculin A has also other sites of action than thymosin h4 binding of actin, making it important to develop more specific derivatives of the toxin (19) . Following latrunculin A addition, the morphology of thymosin h4-overexpressing AdoMetDC transfectants changed to a ball-and-stick appearance. The outermost long protrusions of the cells were much more resistant to the drug action. Similarly, in the work of Spector et al. (61) , the long and thick processes characteristic of morphologically differentiated neuroblastoma cells were also minimally affected even after hours in high toxin concentration. Further, two populations of actin filaments, sensitive stress fibers at the center and more resistant cortical filaments at the cell periphery, have been seen following thymosin h4 overexpressioninduced actin disassembly (59, 60, 64) .
In our study, latrunculin A seemed to prevent cytokinesis. Importantly, latrunculin A was found to fully inhibit the invasive growth of Amdc-s and Amdc-as cells in three-dimensional Matrigel invasion assays. Even when the toxin was added to the already formed invasive colonies, the invasion was blocked and the colonies further regressed. In earlier studies, thymosin h4 has been suggested to facilitate tumor angiogenesis and metastasis, but the mechanisms involved have remained unclear. Recently, Philp et al. (65) found that the actin-binding site of thymosin h4 is important for angiogenesis. Our data with latrunculin A, inhibiting the binding of thymosin h4 to actin, show that the actin-binding site could be similarly important for invasion. As both invasion and angiogenesis are essential for cancer spreading and metastasis, thymosin h4 might be an excellent target to interfere with these two processes. These data should encourage the development and testing of specific drugs for thymosin h4, interfering either with its upregulation or actin sequestering function, for the treatment of thymosin h4-overexpressing tumors with high metastatic potential.
